Mastocytosis / mast cell disorder assessment

A specialist assessment to find out whether symptoms such as flushing, itching, severe allergic reactions or unexplained collapse are caused by a mast cell disorder, including mastocytosis.

✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review

In short

The assessment works out whether a mast cell disorder, such as mastocytosis, is behind symptoms like flushing, itching, collapse or anaphylaxis.
No single test gives the answer — diagnosis usually combines tryptase, a KIT D816V gene test, and sometimes a skin or bone marrow biopsy.
Most cutaneous and indolent mast cell disease has a good outlook, but anaphylaxis risk must be taken seriously throughout.
If you are at risk of severe reactions, you may need adrenaline auto-injectors and a trigger plan during the assessment, not only after a diagnosis — current UK guidance is to be given two auto-injectors and to carry both at all times if you are prescribed them.

A plain-English summary. The detail — including risks and recovery — is below.

At a glance

TypeSpecialist assessment with tests

AnaestheticNot needed for the assessment itself

How long it takesInitial appointment about 30–60 minutes; tests are arranged separately

Hospital stayUsually outpatient; a bone marrow biopsy, if needed, is a day-case procedure

Time off workUsually none for the assessment

When you'll see resultsWeeks, as several tests are often combined

On the NHS?Available on the NHS when clinically indicated; also offered privately

A general guide. Your specialist will give you advice for your situation.

Best fit

Can confirm or make a mast cell disorder unlikely, ending uncertainty.

Pause if

If anaphylaxis is the immediate problem, emergency treatment and a basic allergy plan come first; the full assessment follows.

Main recovery point

History, skin examination and initial blood tests. You leave with advice on triggers and, if needed, an interim emergency plan.

Good aftercare

A written diagnosis or explanation, with the type of disorder where confirmed.

First appointment

History, skin examination and initial blood tests. You leave with advice on triggers and, if needed, an interim...

Days to weeks

Further tests (gene test, biopsy or urine collection) are arranged and processed. A skin biopsy site heals over a...

Results appointment

The specialist explains whether a mast cell disorder is confirmed, the type, and what it means for you.

Ongoing

A treatment and emergency plan is agreed, with any monitoring or onward referral, for example to haematology for...

Medical line illustration of skin assessment with a dermatoscope for Mastocytosis / mast cell disorder assessment. — Illustration only - not a diagnosis, medical advice or a promise of result. Your anatomy and treatment plan may differ. Vuemedics does not publish before-and-after photos.

What is a mastocytosis or mast cell disorder assessment?

Mast cells are immune cells that release chemicals such as histamine and tryptase. In mast cell disorders there are either too many mast cells (as in mastocytosis) or mast cells that release their contents too readily, causing symptoms like flushing, itching, hives, tummy pain, low blood pressure, or severe allergic reactions (anaphylaxis).

This assessment is a careful specialist review, usually by an allergist, immunologist or sometimes a haematologist or dermatologist, to work out whether a mast cell disorder explains your symptoms. It combines a detailed history and examination with tests such as baseline tryptase, a KIT D816V gene test, and sometimes a skin or bone marrow biopsy.

The assessment can confirm or make a mast cell disorder unlikely, classify the type, and guide treatment and emergency planning. It cannot, by itself, predict every future reaction. A key safety point: if you have had anaphylaxis, you may need an adrenaline auto-injector and a written emergency plan while the assessment is ongoing, not only once a diagnosis is confirmed.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

History and trigger review

A detailed account of your symptoms, what brings them on (such as heat, stings, certain medicines, exercise or stress), how severe they are, and any episodes of collapse or anaphylaxis.

Skin examination

Looking for skin signs of mastocytosis, such as red-brown spots (maculopapular cutaneous mastocytosis, also called urticaria pigmentosa) and Darier's sign, where gently rubbing a patch makes it swell and itch.

Baseline tryptase and blood tests

A baseline tryptase level taken when you are well, plus other bloods. A persistently raised baseline is a clue, though it has several possible causes and is not a diagnosis on its own.

KIT D816V gene test

A sensitive blood test for the KIT D816V change, which is found in most people with systemic mastocytosis. If positive, it usually prompts a bone marrow biopsy.

Skin or bone marrow biopsy

A skin biopsy can confirm cutaneous mastocytosis. A bone marrow biopsy is the main way to diagnose and classify systemic mastocytosis when it is suspected.

Urine mast cell mediators

Urine tests for breakdown products of mast cell chemicals, sometimes used to support the picture, often as a timed or 24-hour collection.

Cutaneous vs systemic mastocytosis

Feature	Cutaneous	Systemic
Mainly affects	The skin	Bone marrow and other organs
Common age	Often childhood	Usually adults
Key test	Skin biopsy	Bone marrow biopsy
Childhood outlook	Often improves with age	Less common in children

Many people have skin-limited or indolent disease with a good outlook. Advanced systemic forms are rare. Your specialist will explain which picture fits you.

Preparing for your test

Keep a symptom and trigger diary: what happens, how often, how severe, and what seems to set it off.
List every reaction that needed adrenaline, a hospital visit or felt life-threatening, with dates.
Bring all previous tryptase or allergy results you have.
List your medicines and supplements; some, such as certain painkillers and opioids, can trigger mast cells.
Note any family history of mastocytosis, severe allergies or raised tryptase.
Bring or carry any adrenaline auto-injector you have been prescribed.
Ask in advance whether any tests need timing (for example a baseline tryptase when well) or a urine collection.

What happens

At the first appointment, the specialist takes a detailed history of your symptoms and triggers and examines your skin, sometimes testing for Darier's sign. They will ask carefully about any episodes of anaphylaxis.

Blood tests usually include a baseline tryptase and, where a mast cell disorder is suspected, a KIT D816V gene test. Depending on the findings, you may be offered a skin biopsy or referred for a bone marrow biopsy to confirm and classify systemic disease. Urine tests for mast cell mediators are sometimes added.

Results are pieced together over a few weeks. The specialist then explains whether a mast cell disorder is confirmed, what type, and what it means, and agrees a treatment and emergency plan with you.

Is this test right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

May not be suitable if…

If anaphylaxis is the immediate problem, emergency treatment and a basic allergy plan come first; the full assessment follows.
Tryptase or a gene test alone cannot diagnose or exclude all mast cell disorders, so single tests in isolation are not enough.
Vague or widespread symptoms without supporting evidence may be due to other conditions, which should also be considered.
Mast cell activation syndrome should not be diagnosed without meeting strict criteria, including a documented tryptase rise during episodes.

Delay or rearrange if…

You are within 24 hours of a reaction or unwell, so a baseline tryptase may still be falling.
There is an active infection or recent major illness that could affect results, unless assessment is urgent.
A possible trigger exposure is ongoing and should be controlled before some tests.
Previous results are missing and would change the plan.
Pregnancy is possible and may affect the timing or choice of some investigations.

Alternatives to discuss

Allergy-focused assessment if a specific allergen (such as insect venom or a food) is the main concern.
Haematology assessment if a blood disorder is the leading suspicion.
Dermatology assessment for skin-limited disease.
Watchful monitoring with an emergency plan if symptoms are mild and tests are reassuring.
Genetic testing for hereditary alpha-tryptasemia when a raised baseline tryptase has no other cause.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

What matters most to me?

Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.

What are all my options?

Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.

What would make me pause?

Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.

What happens if I do nothing today?

For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.

Benefits

Can confirm or make a mast cell disorder unlikely, ending uncertainty.
Classifies the type, which guides treatment and outlook.
Identifies your triggers so you can avoid them where possible.
Leads to a clear emergency plan, including adrenaline auto-injectors where needed.
Flags any need for monitoring or referral, for example to haematology for systemic disease.
Helps with planning safe care for surgery, anaesthesia, pregnancy or vaccinations.

Risks & complications

More common

Bruising or soreness from blood tests
Uncertainty while waiting for several tests to come together
A raised tryptase without a clear cause, needing further tests
Discomfort or bruising from a skin biopsy if one is done

Less common

Anxiety about a possible diagnosis or about future reactions
Inconclusive results needing repeat testing or referral
Pain, bruising or, rarely, infection at a bone marrow biopsy site

Rare but serious

A severe reaction during the assessment if a trigger is encountered — managed with emergency treatment
Bleeding or infection after a biopsy
Finding an advanced or associated blood disorder that needs urgent further care

The main risk specific to mast cell disorders is anaphylaxis, which can be unpredictable and, rarely, severe. Make sure you have an emergency plan and, if advised, an adrenaline auto-injector while you are being assessed. Ask which medicines, foods or situations to avoid, and what to do if you react. Most people are found to have skin-limited or indolent disease with a good outlook, but the seriousness of anaphylaxis means it must be planned for.

Published figures to discuss

Mast cell disorders vary widely, from skin-limited disease to rare advanced systemic forms, so a single set of figures does not apply to everyone. The chance and severity of anaphylaxis differ between individuals and triggers. Because robust UK-wide rates for these outcomes vary by population and disease type, exact percentages are not quoted here; your specialist can give a personal estimate.

Figure	Reported range	How to interpret it	Source / confidence
Systemic mastocytosis among people with persistently raised baseline tryptase	Uncommon, but more likely when baseline tryptase is clearly elevated or symptoms fit	Baseline tryptase above 20 micrograms/L is one minor diagnostic clue, not a diagnosis by itself.	Diagnosis of primary mast cell disorders in anaphylaxis: KIT D816V in blood — PubMedpubmed.ncbi.nlm.nih.govSource-linked context
Hereditary alpha-tryptasaemia	Relatively common genetic explanation for raised baseline tryptase; often quoted around 4 to 6% in some populations	It may explain a raised tryptase without mastocytosis, but symptoms still need clinical interpretation.	Diagnosis of primary mast cell disorders in anaphylaxis: KIT D816V in blood — PubMedpubmed.ncbi.nlm.nih.govPublished figure
Anaphylaxis in systemic mastocytosis	Higher than average, especially with venom allergy	Patients may need venom assessment, adrenaline training and peri-operative precautions.	Guide sourcesClinical context
Osteoporosis or fragility fracture in systemic mastocytosis	Recognised complication	Bone-density assessment is often part of a thorough work-up.	Diagnosis of primary mast cell disorders in anaphylaxis: KIT D816V in blood — PubMedpubmed.ncbi.nlm.nih.govSource-linked context

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

There is no physical recovery from the assessment itself, unless you have a biopsy. “Afterwards” mostly means combining test results and agreeing a plan.

First appointment

History, skin examination and initial blood tests. You leave with advice on triggers and, if needed, an interim emergency plan.

Days to weeks

Further tests (gene test, biopsy or urine collection) are arranged and processed. A skin biopsy site heals over a week or two; a bone marrow biopsy site is usually sore for a few days.

Results appointment

The specialist explains whether a mast cell disorder is confirmed, the type, and what it means for you.

Ongoing

A treatment and emergency plan is agreed, with any monitoring or onward referral, for example to haematology for systemic disease.

What's normal — and not a worry

Mild bruising at blood-test or biopsy sites
No change in your symptoms from the assessment itself
A wait of some weeks while tests are combined
Mixed feelings — relief, worry, or frustration — while results come together

Aftercare

Follow the agreed trigger-avoidance advice as far as is practical.
Carry two in-date adrenaline auto-injectors with you at all times if prescribed (current UK guidance is to have two available in case a second dose is needed), and check the expiry dates.
Keep your written emergency plan with you and make sure family or carers know it.
Tell other clinicians (including dentists and anaesthetists) that you may have a mast cell disorder before any procedure.
Look after a biopsy site as advised and watch for signs of infection.
Attend follow-up and any monitoring appointments.
Keep copies of your results, including your baseline tryptase.

Before your test

Symptom and trigger diary
List of reactions needing adrenaline or hospital care, with dates
Current medicines and supplements list
Previous tryptase and allergy results
Two in-date adrenaline auto-injectors carried, if prescribed
Family history of mast cell disease or severe allergy noted
Questions about emergency planning written down

⚠ Get urgent help if…

Sudden breathing difficulty, wheeze or throat tightness — use your adrenaline auto-injector if prescribed and call 999
Swelling of the lips, tongue or throat
Feeling faint, collapsing or a sudden drop in blood pressure
Widespread flushing or hives with feeling unwell
Severe, unexplained abdominal pain, vomiting or diarrhoea
Fever, drenching night sweats, unexplained weight loss or easy bruising (possible signs of advanced disease)
Heavy bleeding, increasing pain or signs of infection after a biopsy

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A clear result means the specialist can say whether a mast cell disorder is present and, if so, which type. Confirming systemic mastocytosis usually relies on a bone marrow biopsy alongside tryptase, the KIT D816V gene test and other findings, judged against internationally agreed criteria. Cutaneous disease is often confirmed on the skin appearance and a biopsy.

A normal assessment can be reassuring, but symptoms may still need explaining and managing, and a normal tryptase does not rule out anaphylaxis. Even when a disorder is confirmed, the assessment cannot predict exactly when reactions will happen, which is why trigger avoidance and an emergency plan matter.

How long it lasts

Mast cell disorders are long-term conditions, but many people, especially with skin-limited or indolent disease, remain stable for years. Children with cutaneous mastocytosis often improve as they grow. Your specialist will advise whether and how often you need monitoring, and a diagnosis or plan can be reviewed if your symptoms change.

Related tests, treatments or support

The assessment usually combines several tests rather than relying on one. Tryptase, the KIT D816V gene test, urine mediators and biopsies are interpreted together. Allergy testing may be added to look for specific triggers such as insect venom, and genetic testing for hereditary alpha-tryptasemia may be considered when the baseline tryptase is raised without another cause.

Follow-up & long-term care

You should be told your results and given a written diagnosis or explanation, a treatment plan and an emergency plan. Systemic disease is often managed jointly with haematology, sometimes at a specialist centre. Follow-up depends on the type of disorder and may include repeat tryptase, monitoring blood tests and review of your medicines and emergency plan.

Carry two in-date adrenaline auto-injectors at all times if prescribed, and renew them before they expire.
Review your trigger list and emergency plan at follow-up.
Have repeat tryptase or monitoring blood tests if advised.
Tell anaesthetists and dentists about your condition before procedures so safe medicines are chosen.
Seek specialist advice before pregnancy, surgery or new long-term medicines.

Repeat, follow-on and what comes next

Diagnosis often takes several tests over weeks, and some results are repeated to confirm them.
A raised tryptase or borderline finding may need further testing rather than giving an immediate answer.
A diagnosis or plan can be revised as symptoms change or new information emerges.
If advanced disease is suspected, care is usually escalated to haematology or a specialist centre.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

A written diagnosis or explanation, with the type of disorder where confirmed.
A clear, written emergency plan and an adrenaline auto-injector where indicated, with training.
A named specialist and a route to contact them with questions or further reactions.
Joint care with haematology or a specialist centre for systemic disease.
A plan for monitoring, repeat tests and review of triggers and medicines.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

The length and complexity of the specialist consultation
Which tests are needed (tryptase, KIT D816V gene test, urine mediators, biopsies)
Whether a skin biopsy or bone marrow biopsy is required and where it is done
Laboratory and reporting fees, and how quickly results are returned
Follow-up appointments to combine results and agree a plan
Whether joint care with haematology or a specialist centre is needed

Make sure your written quote includes

The specialist consultation fee
Each test that is planned and its cost (tryptase, gene test, biopsies, urine tests)
Any biopsy procedure and laboratory fees
Follow-up appointments to review results
How and when results will be reported to you
What happens, and what it costs, if results are inconclusive or further tests are needed
Cancellation and rebooking policy

On the NHS? Assessment for mast cell disorders is available on the NHS when clinically indicated, often through allergy, immunology, dermatology or haematology services; private assessment may be used for faster access or a specialist opinion.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Choosing a specialist safely

Check the specialist is on the GMC Specialist Register for this area.
Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Questions to ask your medical professional

Take this to your consultation. A good specialist will welcome every one of these.

Which type of mast cell disorder are you assessing me for, and which tests will tell us?
Do I need an adrenaline auto-injector and emergency plan now, while we wait for results?
What are my likely triggers and which medicines should I avoid?
Will I need a bone marrow biopsy, and what does it involve?
If systemic disease is found, will I be referred to a specialist centre or haematology?
What does this mean for surgery, anaesthesia, pregnancy or vaccinations?
Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
Will you be the specialist who carries out my test, and who looks after me afterwards?
What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
What does a realistic result look like — and what can this test not achieve?
What are my options, including waiting, doing nothing for now, or choosing a different approach?
Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Frequently asked questions

Is mastocytosis a type of cancer?

Most forms are not cancer. Cutaneous and indolent systemic mastocytosis usually have a good outlook. Advanced systemic forms, which are rare, behave more like a blood disorder and are managed by haematology. The assessment is partly to tell these apart safely.

What is the difference between mastocytosis and MCAS?

Mastocytosis means there are too many mast cells, confirmed on tests such as a biopsy and gene test. Mast cell activation syndrome (MCAS) means mast cells release their contents too readily without an excess of cells. Diagnosing MCAS needs strict criteria, including evidence of a tryptase rise during episodes, so it should be assessed by a specialist.

Will I need a bone marrow biopsy?

Not always. It is mainly used when systemic mastocytosis is suspected, often after a positive KIT D816V blood test or a persistently high tryptase. Many people are diagnosed or reassured without one.

Can a normal tryptase rule out a mast cell disorder?

Not completely. A normal baseline tryptase makes systemic mastocytosis less likely but does not exclude all mast cell problems, and it does not rule out anaphylaxis. Results are read alongside your symptoms and other tests.

Should I have an adrenaline auto-injector while being assessed?

If you have had anaphylaxis or are judged at risk, yes — you may be prescribed one and trained to use it during the assessment, not only after a diagnosis is confirmed. Current UK guidance (NICE NG258) is that anyone prescribed an adrenaline auto-injector should be given two and carry both at all times, in case a second dose is needed before help arrives. Ask your specialist.

What happens if I have a severe reaction during or after the assessment?

Call 999 and use your adrenaline auto-injector straight away if you have one. In hospital you will be watched for a period after the reaction settles. Under current UK guidance (NICE NG258), how long you are observed depends on how you responded: a shorter observation may be enough after a quick, complete recovery from a single dose of adrenaline, provided you have two in-date injectors, have been trained to use them and have support at home; a longer stay (at least 6 or, in some cases, 12 hours) is advised if you needed more than one dose, had breathing problems, or have previously had a delayed 'second-wave' reaction. Your team will decide what is safe for you.

Is this assessment available on the NHS?

Yes, when there is a clinical reason, usually through an allergy, immunology, dermatology or haematology service. It can also be done privately, often for faster access or a specialist opinion.

Find a verified specialist for mastocytosis / mast cell disorder assessment

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

No verified consultants list this procedure yet — browse the full directory.

See all specialists for mastocytosis / mast cell disorder assessment →

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: DermNet — Mastocytosis (clinical overview and diagnostic criteria) UK Mastocytosis Support Group Mast Cell Action (UK charity) NICE NG258 — Anaphylaxis: assessment and referral after emergency treatment North West London Pathology — serum mast cell tryptase Diagnosis of primary mast cell disorders in anaphylaxis: KIT D816V in blood — PubMed Tryptase genotyping in systemic mastocytosis — PMC review NICE NG258 — period of observation after anaphylaxis NICE NG258 — information for the public

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.